RecruitingPhase 2NCT04547439

Sleep, Diabetic Retinopathy and Melatonin

Sleep and Circadian Regulation in Diabetic Retinopathy: The Role of Intrinsically Photosensitive Retinal Ganglion Cells and Melatonin Supplementation

Sponsor

University of Illinois at Chicago

Enrollment

42 participants

Start Date

Feb 3, 2021

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus Diabetic Retinopathy

Summary

This study explores the use of melatonin in patients with diabetic retinopathy

Eligibility

Min Age: 40 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Melatonin and Placebo for people with diabetes mellitus and diabetic retinopathy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.